beta-(5-hydroxy-2-pyridyl)alanine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, FS; Huang, CF; Lee, O; Li, EI; Lian, JF; Liou, JP; Pan, SL; Teng, CM; Wang, CL; Wang, HP | 1 |
| Arce, CA; Barra, HS; Bisig, CG; Contin, MA; Purro, SA | 1 |
2 other study(ies) available for beta-(5-hydroxy-2-pyridyl)alanine and Experimental Neoplasms
| Article | Year |
|---|---|
Azatyrosinamides: novel RAS-related anticancer agents.
Topics: Alanine; Animals; Antineoplastic Agents; Genes, ras; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Neoplasms, Experimental; NIH 3T3 Cells; Xenograft Model Antitumor Assays | 2013 |
Post-translational incorporation of the antiproliferative agent azatyrosine into the C-terminus of alpha-tubulin.
Topics: Alanine; Animals; Antibiotics, Antineoplastic; Brain Chemistry; Carboxypeptidases; Cell Division; Cell Extracts; Cell Line; Microtubules; Neoplasms, Experimental; Protein Processing, Post-Translational; Rats; Rats, Wistar; Tubulin; Tumor Cells, Cultured | 2003 |